VITR.ST - Vitrolife AB (publ)
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 226.20 |
| Open | 224.00 |
| Bid | 223.80 x 0 |
| Ask | 224.20 x 0 |
| Day's Range | 218.20 - 226.20 |
| 52 Week Range | 143.60 - 332.60 |
| Volume | |
| Avg. Volume | 281,477 |
| Market Cap | 30.367B |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | 71.17 |
| EPS (TTM) | 3.15 |
| Earnings Date | Jul 14, 2023 |
| Forward Dividend & Yield | 0.85 (0.39%) |
| Ex-Dividend Date | Apr 28, 2023 |
| 1y Target Est | 308.75 |
Fair Value
Related Research
PR NewswireReport from Annual General Meeting of Vitrolife AB (publ)
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
PR NewswireVitrolife AB: Interim report Q1, 2023: Good start to the year
Vitrolife AB: Interim report Q1, 2023: Good start to the year
PR NewswireVitrolife: Conference call interim report
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1, 2023. The presentation will be held in English.
PR NewswireVitrolife Group Annual and Sustainability Report 2022
Vitrolife Group has today published its Annual and Sustainability Report for 2022.
PR NewswireNotice to attend the Annual General Meeting of Vitrolife AB (publ)
The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on Thursday 27 April 2023 at 4.00 pm at the Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden. Notice of attendance at the Annual General Meeting shall be given no later than Friday 21 April 2023.
PR NewswireVitrolife AB Fourth quarter and full year report 2022: Strong profitable growth
Vitrolife AB Fourth quarter and full year report 2022: Strong profitable growth
PR NewswireBronwyn Brophy is appointed new CEO of Vitrolife AB (publ)
Bronwyn Brophy is Irish and has extensive experience of leading positions in Global Life Science and Medtech companies such as Thermo Fisher Scientific, Medtronic and Johnson & Johnson. The last years within Thermo Fischer Bronwyn Brophy was heading the Immunodiagnostics Division globally and before that served as President of the EMEA region.
PR NewswireVitrolife AB (publ): Conference call Year-end report, 2022
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the Year-end report, 2022. The presentation will be held in English.
PR NewswireCorrection press release: Vitrolife´s CEO has purchased shares
Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 SEK. The total holdings of shares amount to 25,000.
PR NewswireVitrolife´s CEO has purchased shares
Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 MSEK. The total holdings of shares amount to 25,000.
PR NewswireVitrolife AB (publ) Interim report Q3, 2022: Actions done and synergies ahead
Vitrolife AB (publ) Interim report Q3, 2022: Actions done and synergies ahead
PR NewswireVitrolife AB: Conference call interim report
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report January - September 2022. The presentation will be held in English.
PR NewswireElection committee for Vitrolife AB (publ)
The following people have been appointed as members of Vitrolife's election committee for the Annual General Meeting in 2023:
PR NewswireVitrolife´s CEO to retire
Today, Thomas Axelsson, CEO of Vitrolife AB (publ), informed the Board of Directors of his desire and intention to retire and be released from his position. Consequently, the process to find a new CEO to replace Thomas will immediately begin and will be led by Jon Sigurdsson, Chairman of the Board. Thomas will remain as the CEO until the recruitment process is finalized.
PR NewswireVitrolife AB (publ) Interim report Q2, 2022: Together for successful growth
Vitrolife AB (publ) Interim report Q2, 2022: Together for successful growth
PR NewswireVitrolife AB (publ): Conference call interim report
Invitation to attend Vitrolife's conference call regarding presentation of the interim report January – June 2022. The presentation will be held in English.